Ligand Reports First Quarter 2016 Financial Results
SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three months ended March 31, 2016, and provided an operating forecast and program updates.
Financial highlights for the first quarter of 2016 include:
• First quarter total revenues were $29.6 million, including royalty revenues of $14.4 million.
Financial highlights for the first quarter of 2016 include:
• First quarter total revenues were $29.6 million, including royalty revenues of $14.4 million.